利用正电子发射断层扫描（PET）进行分期与“威尔·罗杰斯”效应：重新定义癌症患者的预后和生存情况。 - Suppr

Suppr

超能文献

Staging with PET and the "Will Rogers" effect: redefining prognosis and survival in patients with cancer.

作者信息

Basu Sandip, Alavi Abass

出版信息

Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):1-4. doi: 10.1007/s00259-007-0506-2.

DOI:10.1007/s00259-007-0506-2

PMID:17828536

Abstract

摘要

相似文献

Staging with PET and the "Will Rogers" effect: redefining prognosis and survival in patients with cancer.

Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):1-4. doi: 10.1007/s00259-007-0506-2.

Positron emission tomography in the staging of esophageal cancer.

Rays. 2006 Jan-Mar;31(1):9-12.

Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis.

J Clin Oncol. 2010 Apr 20;28(12):2108-13. doi: 10.1200/JCO.2009.25.4151. Epub 2010 Mar 22.

18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) imaging in the staging and prognosis of inflammatory breast cancer.

Cancer. 2009 Nov 1;115(21):5038-47. doi: 10.1002/cncr.24534.

PET/CT: will it change the way that we use CT in cancer imaging?

Cancer Imaging. 2006 Oct 31;6(Spec No A):S52-62. doi: 10.1102/1470-7330.2006.9012.

Evaluation of fluorodeoxyglucose positron-emission tomography with computed tomography for staging of urothelial carcinoma.

BJU Int. 2010 Sep;106(5):658-63. doi: 10.1111/j.1464-410X.2010.09212.x.

Has integrated 18F FDG PET/CT improved staging, reduced early recurrence or increased survival in oesophageal cancer?

Surgeon. 2015 Feb;13(1):19-33. doi: 10.1016/j.surge.2013.09.002. Epub 2013 Oct 24.

Clinical utility of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the staging of patients with potentially resectable esophageal cancer.

J Thorac Oncol. 2013 Dec;8(12):1563-9. doi: 10.1097/JTO.0000000000000006.

¹⁸F-FDG PET/CT for Staging and Restaging of Breast Cancer.

J Nucl Med. 2016 Feb;57 Suppl 1:17S-26S. doi: 10.2967/jnumed.115.157859.

[Application and future prospect of 18F-FLT PET-CT in guiding delineation of biological target volume].

Zhonghua Zhong Liu Za Zhi. 2009 Jan;31(1):1-4.

引用本文的文献

Pancreas cancer survival in the gemcitabine era.

Clin Med Oncol. 2008;2:405-13. doi: 10.4137/cmo.s334. Epub 2008 Apr 29.

Personalized versus evidence-based medicine with PET-based imaging.

Nat Rev Clin Oncol. 2010 Nov;7(11):665-8. doi: 10.1038/nrclinonc.2010.121. Epub 2010 Aug 10.

[The Will Rogers phenomenon and its impact on imaging diagnostics].

Radiologe. 2009 Apr;49(4):348-54. doi: 10.1007/s00117-008-1733-7.

本文引用的文献

Bone marrow and not bone is the primary site for skeletal metastasis: critical role of [18F]fluorodeoxyglucose positron emission tomography in this setting.

J Clin Oncol. 2007 Apr 1;25(10):1297; author reply 1297-9. doi: 10.1200/JCO.2006.10.0123.

Should FDG-PET imaging be considered on a routine basis in clinical trials for carcinoma of esophagus to assure uniformity of protocols among sites?

Eur J Nucl Med Mol Imaging. 2007 Apr;34(4):604-5. doi: 10.1007/s00259-006-0315-z.

The added value of metabolic imaging with FDG-PET in oesophageal cancer: prognostic role and prediction of response to treatment.

Eur J Nucl Med Mol Imaging. 2006 Jul;33(7):753-8. doi: 10.1007/s00259-006-0147-x.

Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy.

Breast Cancer Res Treat. 2006 May;97(1):91-6. doi: 10.1007/s10549-005-9095-6. Epub 2005 Dec 1.

Survival after surgery for oesophageal cancer: a population-based study.

Lancet Oncol. 2005 Nov;6(11):864-70. doi: 10.1016/S1470-2045(05)70347-8.

Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial.

Lancet Oncol. 2005 Sep;6(9):659-68. doi: 10.1016/S1470-2045(05)70288-6.

Value of PET-CT fusion imaging in avoiding potential pitfalls in the interpretation of 18F-FDG accumulation in the distal oesophagus.

Eur J Nucl Med Mol Imaging. 2005 Aug;32(8):990-2. doi: 10.1007/s00259-005-1836-6.

Applications of fluorodeoxyglucose-PET imaging in the detection of infection and inflammation and other benign disorders.

Radiol Clin North Am. 2005 Jan;43(1):121-34. doi: 10.1016/j.rcl.2004.07.005.

Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer.

Radiol Clin North Am. 2005 Jan;43(1):1-21, ix. doi: 10.1016/j.rcl.2004.09.001.

Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders.

Semin Nucl Med. 2004 Oct;34(4):313-29. doi: 10.1053/j.semnuclmed.2004.06.006.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验